visibiome
Cell therapyexperimental
Clinical trial activity
10 trials · 19 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
4
Phase 3
2
Phase 4
0
Earliest trial started Sep 1, 2013 (NCT02011542)
Timeline
Indications
Mechanism of action
- microbiotaTissue restoration
microbiota tissue restoration
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- visbiome
- visibiome
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06898788 | Early Phase 1 (Phase 1) | May 15, 2025 | National Center for Complementary and Integrative Health (NCCIH), University of California, San Francisco |
| NCT04281407 | N/A | Jan 3, 2020 | University of Washington |
| NCT04141761 | Phase 2 | Apr 1, 2019 | Medical College of Wisconsin |
| NCT03524638 | N/A | May 15, 2018 | University of Louisville |
| NCT02903030 | Early Phase 1 (Phase 1) | Aug 1, 2016 | Autism Speaks, Autism Treatment Network, Ohio State University |
| NCT02706717 | Phase 2 | Apr 1, 2016 | AIDS Clinical Trials Group, Exegi Pharma, LLC, Johns Hopkins University, National Institute of Allergy and Infectious Diseases (NIAID), University of Alabama, Birmingham |
| NCT02441244 | Phase 2 | Nov 1, 2015 | CIHR Canadian HIV Trials Network, University of Toronto |
| NCT02441231 | Phase 2 | Nov 1, 2015 | CIHR Canadian HIV Trials Network, University of Toronto |
| NCT03078530 | Phase 2/Phase 3 (Phase 3) | Sep 13, 2013 | Department of Defense, Department of Veteran Affairs, VA Salt Lake City Health Care System |
| NCT02011542 | Phase 2/Phase 3 (Phase 3) | Sep 1, 2013 | Department of Defense, Department of Veteran Affairs, University of Utah |
Showing 10 of 10 trials
Page 1 / 1
Organizations
Research & Development (19)
19 organizations
Page 1 / 1